About 11.8 million consumers nationwide enrolled in 2018 Obamacare exchange plans, a 3 percent drop from 2017 when 12.2 million consumers signed up, according to a final government tally released by the Centers for Medicare and Medicaid Services.
Global drugmakers are looking to a tiny biotech’s $850,000 therapy for a rare type of blindness as a model for getting paid for highly expensive – and effective – new medicines.
Abbott Laboratories said its newly launched glucose monitoring device would be covered by the Centers for Medicare & Medicaid Services, expanding its usage to millions of diabetes patients in the United States.
About 8.7 million people enrolled in healthcare plans for 2018 using the federal Obamacare marketplace, according to updated government figures.
The Wall Street Journal reported that Theranos Inc. secured a loan from Fortress Investment Group.
Growth in healthcare spending in the United States slowed in 2016 following two years of expansion under the Affordable Care Act.
The U.S. government is considering setting new payment methods aimed at curbing costs for Medicare and Medicaid coverage of breakthrough medical treatments with very high prices, particularly novel gene-based therapies for cancer and other diseases, a top health official said.
The U.S. Centers for Medicare and Medicaid Services said it plans to spend $10 million on advertising for the upcoming Obamacare open enrollment period that starts in November 2017, a sharp cut from the $100 million spent during 2016.
Ohio’s Department of Insurance said non-profit managed care company CareSource will sell health plans in Paulding County in 2018 – the last county in the United States that would have been without Obamacare individual coverage during the year.
The Trump administration will make cost-sharing payments to insurance companies under Obamacare for August 2017, a White House spokesman said, but the announcement did little to quell long-term concerns about the insurance market.